AC

Anita Chhabra

Active Director Director DIN 08171517
DIN 08171517 First appointment Feb 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2023
Shareholding value •••• Premium profile

About Anita Chhabra

Data last updated:

Anita Chhabra is a Director at Dr. Sid Pharmaceutical Private Limited (since 2023). The company operates in Pharma. Dr. Sid Pharmaceutical Private Limited reported revenue of ₹1.39 Cr (FY 2024).

DIN 08171517
Primary Designation Director
Industry Pharma
First Appointment 02 Feb 2023
Oldest Company Age 6 yrs
Largest company Dr. Sid Pharmaceutical Private Limited · ₹1.39 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director02 Feb 20232020₹1.39 Cr (FY 2024)Active

Board colleagues of Anita Chhabra

NameDINCompanyDesignation
Manohar Lal Chhabra00487309Dr. Sid Pharmaceutical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dr. Sid Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Anita Chhabra

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anita Chhabra

Anita Chhabra currently holds 1 directorship: Dr. Sid Pharmaceutical Private Limited (Director, since 02 Feb 2023, revenue ₹1.39 Cr (FY 2024)).

Anita Chhabra was first appointed on 02 Feb 2023 as Director at Dr. Sid Pharmaceutical Private Limited.

The current boards of Anita Chhabra's companies include Manohar Lal Chhabra (Dr. Sid Pharmaceutical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available